SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-13-387231
Filing Date
2013-10-01
Accepted
2013-10-01 16:26:59
Documents
1
Effectiveness Date
2013-10-01

Document Format Files

Seq Description Document Type Size
1 S-8 POS d604121ds8pos.htm S-8 POS 32649
  Complete submission text file 0001193125-13-387231.txt   33660
Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

IRS No.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-159496 | Film No.: 131127255
SIC: 2836 Biological Products, (No Diagnostic Substances)